Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biohaven’s Nurtec May Be First Migraine Drug For Acute Treatment And Prevention
Mar 31 2020
•
By
Mandy Jackson
Nurtec ODT could be the first oral anti-CGRP drug for migraine prevention • Source: Shutterstock
More from Neurological
More from Therapeutic Category